What is Human Metabolome Technologies Quick Ratio?
Human Metabolome TechnologiesTSE:6090 +0.84%59 Quick Ratio is 5.13 as of Dec. 2025, which is at its 10-year median of 5.13. GuruFocus rates TSE:6090 with a GF Score™ of 59/100 and a GF Value™ of 円529.55 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Human Metabolome Technologies ranks better than 85.51% on this metric.
Human Metabolome Technologies has a quick ratio of 5.13. It generally indicates good short-term financial strength.
The historical rank and industry rank for Human Metabolome Technologies's Quick Ratio or its related term are showing as below:
TSE:6090'
s Quick Ratio Range Over the Past 10 Years
Min: 3.11 Med: 5.13 Max: 16.59
Current: 4.6
During the past 12 years, Human Metabolome Technologies's highest Quick Ratio was 16.59. The lowest was 3.11. And the median was 5.13.
TSE:6090's Quick Ratio is ranked better than 85.51% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.735
vs TSE:6090: 4.60
Human Metabolome Technologies (TSE:6090) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Human Metabolome Technologies Quick Ratio Related Terms
Human Metabolome Technologies Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6090 vs TMO, DHR, IDXX: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Human Metabolome Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Metabolome Technologies Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Human Metabolome Technologies's Quick Ratio falls into.
Human Metabolome Technologies Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies (TSE:6090) has a Quick Ratio of 5.13 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Human Metabolome Technologies and its competitors. This is near median its historical median of 5.13. Over the past decade, Human Metabolome Technologies' Quick Ratio has ranged from 3.11 to 16.59. According to the industry distribution chart, Human Metabolome Technologies ranks #31 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 14.5%.
Is Human Metabolome Technologies' Quick Ratio too high?
Human Metabolome Technologies' current Quick Ratio of 5.13 is near median its 10-year median of 5.13. Over the past 10 years, this metric has ranged from a low of 3.11 to a high of 16.59. The Medical Diagnostics & Research industry median Quick Ratio is 1.74. Human Metabolome Technologies' value of 5.13 is 195.7% above this industry median. Based on the distribution chart, Human Metabolome Technologies ranks #31 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Human Metabolome Technologies has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Human Metabolome Technologies ranks #31 out of 214 companies for Quick Ratio. This places Human Metabolome Technologies in the top 15% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.74. Human Metabolome Technologies' value of 5.13 is 195.7% above this benchmark. Historically, Human Metabolome Technologies' own Quick Ratio has ranged from 3.11 to 16.59 over the past decade. While the company's 10-year median is 5.13 vs. the industry median of 1.74, Human Metabolome Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.74, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Metabolome Technologies's current Quick Ratio of 5.13 is 195.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Human Metabolome Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Metabolome Technologies's current Quick Ratio is 5.13, which is near median its own 10-year median of 5.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円529.55, compared to a current price of 円598.00 — trading 12.9% above its estimated fair value. The current Quick Ratio is 5.13, which is near median its 10-year median of 5.13 and 195.7% above the Medical Diagnostics & Research industry median of 1.74. Human Metabolome Technologies' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Quick Ratio is 5.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?
Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued.
The current stock price of 円598.00 is trading 12.9% above its estimated GF Value™ of 円529.55.
GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.
Key valuation signals for TSE:6090:
Quick Ratio: 5.13 (near median its 10-year median of 5.13)
GF Value™: 円529.55 vs. price of 円598.00 (12.9% above fair value)
Industry Position: 195.7% above the Medical Diagnostics & Research median (#31 of 214)
No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Human Metabolome Technologies Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6090 has been successfully added to your 
